ENVB Enveric Biosciences, Inc. Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 6
- List Date
- 1995-08-24
- CIK
- 0000890821
- Next Earnings
- 2026-11-13
- Headquarters
- Cambridge, MA
- Homepage
- https://www.enveric.com
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for p…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -7.04% | -38.22% | 24.78% | -41.11% | -64.27% | -20.71% | -24.43% |
| Feb | -11.86% | -58.40% | -27.93% | 60.50% | 54.70% | -19.24% | -0.37% |
| Mar | -14.96% | 6.45% | -14.66% | -39.76% | -46.54% | -13.78% | -20.54% |
| Apr | -23.96% | -13.54% | 14.59% | 5.62% | 0.76% | 84.58% | 11.34% |
| May | -8.23% | -25.56% | 131.49% | -16.11% | -7.81% | -42.36% | 5.24% |
| Jun | 0.00% | 2.05% | -24.10% | -18.89% | -1.63% | -38.94% | -13.59% |
| Jul | -16.96% | -39.79% | -18.51% | -19.45% | -0.81% | 8.28% | -14.54% |
| Aug | 4.19% | -9.42% | -18.80% | -3.90% | -1.74% | -14.37% | -7.34% |
| Sep | -1.43% | -24.91% | 12.00% | -7.08% | -41.34% | 8.39% | -9.06% |
| Oct | -14.56% | -21.43% | -22.22% | 15.29% | -28.24% | -5.48%* | -12.77% |
| Nov | -31.22% | -14.07% | -18.23% | -32.87% | -18.93% | -- | -23.06% |
| Dec | -23.77% | -28.52% | -22.62% | 9.37% | -36.54% | -- | -20.42% |
| Total | -81.42% | -96.45% | -43.64% | -75.09% | -94.30% | -65.93% | -76.14% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
Click Frenzy-Pro™ for an AI analysis of this ticker.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
ENVB Options Activity & IV Rank
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 250
Period: 252 trading days
High volatility - stock moves more than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $44K | #3056 of 3138 | new | 13F | |
| Citadel Hedge fund Ken Griffin | $19K | #6174 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
ENVB Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
ENVB Insider Trading (Form 4)
Latest: 2026-06-03| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | Peter J. Facchini | Chief Innovation Officer | Award (A) | +25,000 | — | EDGAR | |
| 2026-06-03 | Kevin Michael Coveney | Chief Financial Officer | Award (A) | +133,333 | — | EDGAR | |
| 2026-06-03 | Marcus Schabacker | Director | Award (A) | +18,518 | — | EDGAR | |
| 2026-06-03 | Sheila DeWitt | Director | Award (A) | +18,518 | — | EDGAR | |
| 2026-06-03 | Joseph Edward Tucker | Chief Executive Officer | Award (A) | +201,124 | — | EDGAR | |
| 2026-06-03 | Michael D Webb | Director | Award (A) | +18,518 | — | EDGAR | |
| 2026-06-03 | Frank Pasqualone | Director | Award (A) | +18,518 | — | EDGAR | |
| 2026-06-03 | George A. Kegler | Director | Award (A) | +18,518 | — | EDGAR | |
| 2025-12-30 | Joseph Edward Tucker | Chief Executive Officer | Award (A) | +60,296 | — | EDGAR | |
| 2025-12-30 | Frank Pasqualone | Director | Award (A) | +7,633 | — | EDGAR | |
| 2025-12-30 | Michael D Webb | Director | Award (A) | +7,633 | — | EDGAR | |
| 2025-12-30 | Kevin Michael Coveney | Chief Financial Officer | Award (A) | +40,198 | — | EDGAR | |
| 2025-12-30 | Sheila DeWitt | Director | Award (A) | +7,633 | — | EDGAR | |
| 2025-12-30 | George A. Kegler | Director | Award (A) | +7,633 | — | EDGAR | |
| 2025-12-30 | Marcus Schabacker | Director | Award (A) | +7,633 | — | EDGAR |
ENVB Insider Holdings
8 insiders · @ $1.38| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Joseph Edward Tucker | Chief Executive Officer | 271,556 | $374.7K | $0 | 9 | 2026-06-03 |
| 2 | Kevin Michael Coveney | Chief Financial Officer | 180,746 | $249.4K | $0 | 6 | 2026-06-03 |
| 3 | Peter J. Facchini | Chief Innovation Officer | 27,814 | $38.4K | $0 | 7 | 2026-06-03 |
| 4 | Frank Pasqualone | Director | 26,423 | $36.5K | $2.1K | 4 | 2026-06-03 |
| 5 | Marcus Schabacker | Director | 26,418 | $36.5K | $0 | 4 | 2026-06-03 |
| 6 | George A. Kegler | Director | 26,418 | $36.5K | $0 | 4 | 2026-06-03 |
| 7 | Michael D Webb | Director | 26,416 | $36.5K | $0 | 3 | 2026-06-03 |
| 8 | Sheila DeWitt | Director | 26,306 | $36.3K | $0 | 3 | 2026-06-03 |
ENVB Board & Officers
As of SEC filings through Jun 3, 2026Directors 6
- George A. Kegler · since Dec 30, 2020
- Marcus Schabacker · since Dec 30, 2020
- Joseph Edward Tucker · since Sep 16, 2021
- Michael D Webb · since Jun 13, 2022
- Frank Pasqualone · since Jul 13, 2022
- Sheila DeWitt · since May 28, 2024
Officers 3
- Joseph Edward Tucker · Chief Executive Officer · since Sep 16, 2021
- Kevin Michael Coveney · Chief Financial Officer · since Mar 13, 2023
- Peter J. Facchini · Chief Innovation Officer · listed since Jan 2023
Changes in the last 10 years (47)
| May 28, 2024 | Sheila DeWitt became a director |
| May 18, 2023 | The company announced the departure of Avani Kanubaddi as President and COO in an SEC filing |
| Mar 13, 2023 | Kevin Michael Coveney became Chief Financial Officer |
| Feb 22, 2023 | The company announced the departure of Robert Dickey IV as Chief Financial Officer in an SEC filing |
| Jan 27, 2023 | Peter J. Facchini listed as Chief Innovation Officer (previously Chief Scientific Officer) in SEC filings |
| Sep 9, 2022 | Robert Dickey IV became Chief Financial Officer |
| Jul 13, 2022 | Frank Pasqualone became a director |
| Jun 13, 2022 | Michael D Webb became a director |
| Jun 13, 2022 | Bevin O'Neil became a director |
| May 3, 2022 | The company announced the departure of Bradley George Thompson from the board in an SEC filing |
| Jan 25, 2022 | Avani Kanubaddi listed as President and COO (previously Chief Operating Officer) in SEC filings |
| Oct 18, 2021 | Jillian Marie Hagel listed as Chief Technology Officer (previously Chief Technical Officer) in SEC filings |
| Sep 16, 2021 | Peter J. Facchini became Chief Scientific Officer |
| Sep 16, 2021 | Joseph Edward Tucker became a director |
| Sep 16, 2021 | Joseph Edward Tucker became Chief Executive Officer |
| Sep 16, 2021 | Jillian Marie Hagel became Chief Technical Officer |
| Sep 16, 2021 | Bradley George Thompson became a director |
| May 15, 2021 | Carter Julian Ward became Chief Financial Officer |
| Mar 17, 2021 | Douglas Lind became a director |
| Dec 30, 2020 | TOP Invest LLC became a 10% owner |
| Dec 30, 2020 | Solomon Mayer became a director |
| Dec 30, 2020 | Robert G. Wilkins became Chief Medical Officer |
| Dec 30, 2020 | Marcus Schabacker became a director |
| Dec 30, 2020 | John Van Buiten became Chief Financial Officer |
| Dec 30, 2020 | George A. Kegler became a director |
| Dec 30, 2020 | David Ian Johnson became a director |
| Dec 30, 2020 | David Ian Johnson became CEO and Chairman |
| Dec 30, 2020 | Avani Kanubaddi became Chief Operating Officer |
| Dec 11, 2018 | Thoranath Sukumaran became a director |
| Nov 20, 2018 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 reported in an SEC filing no longer being a 10% owner |
| Nov 20, 2018 | Lokesh Sikaria reported in an SEC filing no longer being a 10% owner |
| Nov 20, 2018 | Lokesh Sikaria Trust Dated 12/14/2012 reported in an SEC filing no longer being a 10% owner |
| Nov 20, 2018 | Chanda Sikaria reported in an SEC filing no longer being a 10% owner |
| Oct 26, 2018 | Sikaria Family 2008 Revocable Trust Dated 02/28/2008 became a 10% owner |
| Oct 26, 2018 | Lokesh Sikaria became a 10% owner |
| Oct 26, 2018 | Lokesh Sikaria Trust Dated 12/14/2012 became a 10% owner |
| Oct 26, 2018 | Chanda Sikaria became a 10% owner |
| Oct 17, 2018 | Barry Kostiner became Chief Financial Officer |
| Aug 16, 2018 | Robert G. Shawah became a director |
| Aug 16, 2018 | James Shad became a director |
| Jul 19, 2018 | Giri Devanur first listed as a 10% owner in an SEC filing |
| Feb 8, 2018 | David P Luci became a director |
| Dec 26, 2017 | Brent Kelton became Chief Executive Officer |
| Aug 23, 2017 | Lone Star Value Co-Invest I, LP first on file as a 10% owner |
| Apr 24, 2017 | Viraj J Patel became Chief Financial Officer |
| Apr 14, 2017 | Giri Devanur no longer listed as a director in SEC filings |
| Apr 14, 2017 | Giri Devanur no longer listed as a 10% owner in SEC filings |
- Prev
- 1
Not reported recently (28)
- Jillian Marie Hagel · Last reported as Chief Technology Officer in an SEC filing dated Jan 27, 2023
- Douglas Lind · Last reported as a director in an SEC filing dated Sep 14, 2022
- Bevin O'Neil · Last reported as a director in an SEC filing dated Jul 5, 2022
- Carter Julian Ward · Last reported as Chief Financial Officer in an SEC filing dated Jan 25, 2022
- John Van Buiten · Last reported as Chief Financial Officer in an SEC filing dated Mar 8, 2021
- Solomon Mayer · Last reported as a director in an SEC filing dated Feb 17, 2021
- David Ian Johnson · Last reported as a director in an SEC filing dated Feb 17, 2021
- TOP Invest LLC · Last reported as a 10% owner in an SEC filing dated Jan 8, 2021
- Robert G. Wilkins · Last reported as Chief Medical Officer in an SEC filing dated Jan 8, 2021
- Brent Kelton · Last reported as Chief Executive Officer in an SEC filing dated Feb 5, 2019
- Thoranath Sukumaran · Last reported as a director in an SEC filing dated Dec 20, 2018
- Barry Kostiner · Last reported as Chief Financial Officer in an SEC filing dated Oct 19, 2018
- Viraj J Patel · Last reported as Chief Financial Officer in an SEC filing dated Sep 14, 2018
- Dimitrios Angelis · Last reported as a director in an SEC filing dated Aug 22, 2018
- David P Luci · Last reported as a director in an SEC filing dated Aug 22, 2018
- Robert G. Shawah · Last reported as a director in an SEC filing dated Aug 22, 2018
- James Shad · Last reported as a director in an SEC filing dated Aug 22, 2018
- Jeffrey E. Eberwein · Last reported as a 10% owner in an SEC filing dated Aug 20, 2018
- Lone Star Value Investors GP LLC · Last reported as a 10% owner in an SEC filing dated Aug 20, 2018
- Lone Star Value Investors LP · Last reported as a 10% owner in an SEC filing dated Aug 20, 2018
- Lone Star Value Management LLC · Last reported as a 10% owner in an SEC filing dated Aug 20, 2018
- Lone Star Value Co-Invest I, LP · Last reported as a 10% owner in an SEC filing dated Aug 20, 2018
- Giri Devanur · Last reported as a 10% owner in an SEC filing dated Jul 19, 2018
- Arthur M Langer · Last reported as a director in an SEC filing dated Feb 15, 2018
- Venkatraman Balakrishnan · Last reported as a director in an SEC filing dated Feb 15, 2018
- Robert G. Pearse · Last reported as a director in an SEC filing dated Feb 12, 2018
- Dhruwa N Rai · Last reported as a director in an SEC filing dated Feb 12, 2018
- Robert Alan Rosenberg · Last reported as a director in an SEC filing dated Jan 26, 2017
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.